Allegion - ALLE Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ALLE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALLE, but not buy additional shares or sell existing shares.
View ALLE analyst ratings or view top-rated stocks.

10 Wall Street research analysts have issued 1-year price objectives for Allegion's shares. Their ALLE share price forecasts range from $110.00 to $132.00. On average, they anticipate the company's stock price to reach $122.78 in the next year. This suggests a possible upside of 18.8% from the stock's current price.
View analysts price targets for ALLE or view top-rated stocks among Wall Street analysts.

Allegion's stock was trading at $105.26 on January 1st, 2023. Since then, ALLE shares have decreased by 1.8% and is now trading at $103.32.
View the best growth stocks for 2023 here.

Allegion saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 1,340,000 shares, an increase of 5.5% from the February 13th total of 1,270,000 shares. Based on an average daily volume of 643,100 shares, the short-interest ratio is presently 2.1 days. Currently, 1.5% of the company's shares are short sold.
View Allegion's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our ALLE earnings forecast.

Allegion plc (NYSE:ALLE) posted its earnings results on Wednesday, February, 22nd. The scientific and technical instruments company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. The scientific and technical instruments company had revenue of $861.50 million for the quarter, compared to the consensus estimate of $849.15 million. Allegion had a net margin of 14.00% and a trailing twelve-month return on equity of 61.54%. Allegion's revenue was up 21.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.11 earnings per share.
Read the conference call transcript.

Allegion announced a quarterly dividend on Thursday, February 9th. Stockholders of record on Wednesday, March 15th will be given a dividend of $0.45 per share on Friday, March 31st. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date of this dividend is Tuesday, March 14th. This is an increase from the stock's previous quarterly dividend of $0.41.
Read our dividend analysis for ALLE.

ETFs with the largest weight of Allegion (NYSE:ALLE) stock in their portfolio include VanEck Morningstar Wide Moat ETF (MOAT), Invesco S&P 500 Equal Weight Industrials ETF (RGI), Democratic Large Cap Core ETF (DEMZ), VanEck Morningstar ESG Moat ETF (MOTE), Nuveen ESG Mid-Cap Growth ETF (NUMG), Principal Quality ETF (PSET), First Trust SMID Cap Rising Dividend Archievers ETF (SDVY) and First Trust Alerian US NextGen Infrastructure ETF (RBLD).

Allegion (NYSE:ALLE) pays an annual dividend of $1.80 per share and currently has a dividend yield of 1.70%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALLE will have a dividend payout ratio of 26.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALLE.

Allegion updated its FY23 earnings guidance on Wednesday, February, 22nd. The company provided EPS guidance of $6.30-6.50 for the period, compared to the consensus earnings per share estimate of $6.06. The company issued revenue guidance of +9.0-10.5% yr/yr to ~$3.57-3.62 billion, compared to the consensus revenue estimate of $3.52 billion.

141 employees have rated Allegion Chief Executive Officer David (Dave) D. Petratis on Glassdoor.com. David (Dave) D. Petratis has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Johnson & Johnson (JNJ), Walmart (WMT), Citigroup (C), AT&T (T), UnitedHealth Group (UNH), Cisco Systems (CSCO) and Nucor (NUE).

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion's stock is owned by many different retail and institutional investors. Top institutional shareholders include Boston Partners (4.59%), AKO Capital LLP (2.95%), Geode Capital Management LLC (2.08%), Ninety One UK Ltd (1.80%), Deutsche Bank AG (1.66%) and Nordea Investment Management AB (1.48%). Insiders that own company stock include David D Petratis, David D Petratis, Douglas P Ranck, Jeffrey N Braun, John H Stone, Patrick S Shannon, Robert C Martens, Shelley A Meador, Timothy P Eckersley, Timothy P Eckersley and Tracy L Kemp.
View institutional ownership trends.

Shares of ALLE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALLE stock can currently be purchased for approximately $103.32.

Allegion (NYSE:ALLE) has a market capitalization of $9.08 billion and generates $3.27 billion in revenue each year. The scientific and technical instruments company earns $458 million in net income (profit) each year or $5.18 on an earnings per share basis.

The company employs 12,300 workers across the globe.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The official website for the company is www.allegion.com. The scientific and technical instruments company can be reached via phone at (531) 254-6200 or via email at michael.wagnes@allegion.com.